drugset / Trial / NCT03040323
Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses
Non-randomizedParallel-groupSingle-blindDiagnostic
Summary
The investigators plan to compare complication and success rates between two methods of ultrasound guidance for biopsy of liver lesions, contrast-enhanced and the current protocol without contrast.
Timeline
- Start
- 2016-12-22
- Primary completion
- 2018-06-30
- Completion
- 2018-07-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumason | Diagnostic / imaging agent | 60.7 mg | Other |
Indications
No indication recorded.